Learn more When a company acquires another business, there's often going to be a premium involved, especially if it's in good ...

Gedatolisib is approved in combination with fulvestrant, with or without palbociclib ...

Crinetics Pharmaceuticals (NASDAQ:CRNX | CRNX Price Prediction) shares have climbed 99% just this week, from $42.03 at Monday ...

MBX Biosciences appointed Steve Hoerter chairman and chief executive, effective immediately, succeeding Kent Hawryluk. Hoerter has served as executive chairman since November 2025 and joined the board ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of ...

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...

Neurocrine Biosciences (NasdaqGS:NBIX) has begun a Phase 2 pediatric study of crinecerfont in children under 4 years with ...

SGPGIMS award-winning toppers urge higher investment in medical research, infrastructure, funding and ethical AI; flag brain drain, paper leaks and violence.

Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications, today announced that the U.S. Food and Drug ...

Steve Hoerter, who was previously executive chairman of the company’s board of directors, has succeeded Kent Hawryluk as CEO ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Gross SC-islet morphology and size were maintained, yet the fraction of NKX6.1-positive β cells fell substantially, pointing ...